Informationen:
Fehler:
ID
14079
Beschreibung
Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone; ODM derived from: https://clinicaltrials.gov/show/NCT02281929
Link
https://clinicaltrials.gov/show/NCT02281929
Stichworte
Versionen (1)
- 27.03.16 27.03.16 -
Hochgeladen am
27. März 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Alcoholic Hepatitis NCT02281929
Eligibility Alcoholic Hepatitis NCT02281929
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Alcoholic Hepatitis NCT02281929
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
patients aged 18-75
boolean
C0001779 (UMLS CUI [1])
jaundice
Item
recent onset of jaundice (<3 months)
boolean
C0022346 (UMLS CUI [1])
alcoholic hepatitis
Item
biopsy proven alcoholic hepatitis (transjugular liver biopsy)
boolean
C0019187 (UMLS CUI [1])
maddreys discriminant function
Item
maddrey's discriminant function ≥ 32, defining severe alcoholic hepatitis
boolean
C0012630 (UMLS CUI [1])
Meld
Item
meld score ≥21
boolean
C1718072 (UMLS CUI [1])
alcohol consumption
Item
alcohol consumption ≥ 40g/day (women) and ≥ 50g/day (men)
boolean
C0001948 (UMLS CUI [1])
Written informed consent
Item
Written informed consent
boolean
C0021430 (UMLS CUI [1])
hypersensitivity to amoxicillin or clavulanic acid
Item
previous severe allergy or hypersensitivity to amoxicillin or clavulanic acid (anaphylactic shock, quincke edema, severe urticaria)
boolean
C0020517 (UMLS CUI [1,1])
C0002645 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0055860 (UMLS CUI [2,2])
C0002645 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0055860 (UMLS CUI [2,2])
hypersensitivity to medication
Item
hypersensitivity to any component of the medication
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
liver injury
Item
history of liver injury
boolean
C0160390 (UMLS CUI [1])
Phenylketonurias
Item
phenylketonuria, because of the presence of aspartame in the powder for the oral suspension
boolean
C0031485 (UMLS CUI [1])
Hepatorenal Syndrome
Item
type 1 hepatorenal syndrome before the initiation of treatment
boolean
C0019212 (UMLS CUI [1])
Liver diseases
Item
severe extrahepatic disease
boolean
C0023895 (UMLS CUI [1])
Malignant Neoplasms
Item
any malignant tumor < 2 years
boolean
C0006826 (UMLS CUI [1])
Gastrointestinal Hemorrhage
Item
uncontrolled gastrointestinal bleeding
boolean
C0017181 (UMLS CUI [1])
Parasitic Diseases, Virus Diseases
Item
ongoing viral or parasitic infection
boolean
C0030499 (UMLS CUI [1])
C0042769 (UMLS CUI [2])
C0042769 (UMLS CUI [2])
Bacterial Infections
Item
untreated bacterial infection.
boolean
C0004623 (UMLS CUI [1])